Low adiponectin level causes vascular remodeling?: A perspective through intravascular ultrasound

Hypertension Research

Volumn 31, Issue 12, 2008, Pages 2099-2101

  Yasu, Takanori ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; BLOOD VESSEL PARAMETERS; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; DIASTOLIC BLOOD PRESSURE; HUMAN; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; NO REFLOW PHENOMENON; NONHUMAN; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN BLOOD LEVEL; SMOOTH MUSCLE FIBER; VASCULAR REMODELING; ANGIOGRAPHY; ANIMAL; BLOOD; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DISEASE MODEL; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADIPONECTIN; ANGIOGRAPHY; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE MODELS, ANIMAL; HUMANS; RISK FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 61949308191     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.2099     Document Type: Note

References (20)

1. Nissen SE, Tuzcu EM, Schoenhagen P, et al, REVERSAL Investigators: Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA 2004; 291: 1071-1080.
2. Berry C, L'Allier PL, Grégoire J, et al: Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression. Circulation 2007; 115: 1851-1857.
3. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1371-1375.
4. Nissen SE, Tuzcu EM, Libby P, et al, CAMELOT Investigators: Effect of antihypertensive agents on cardiovascular events in patients with coronary diseAse and normal blood pressure: The CAMELOT study: a randomized controlled trial. JAMA 2004; 292: 2217-2225.
5. Katayama T, Kubo N, Takagi Y, et al: Relation of atherothrombosis burden and volume detected by intravascular ultrasound to angiographic no-reflow phenomenon during stent implantation in patients with acute myocardial infarction. Am J Cardiol 2006; 97: 301-304.
6. Iwata A, Miura S, Mori K, Kawahara A, Nishikawa H, Saku K: Associations between metabolic factors and coronary plaque growth or arterial remodeling as assessed by intravascular ultrasound in patients with stable angina. Hypertens Res 2008; 31: 1879-1886.
7. Arita Y, Kihara S, Ouchi N, et al: Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002; 105: 2893-2898.
8. Wang Y, Lam KS, Xu JY, et al: Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 2005; 280: 18341-18347.
9. Matsuda M, Shimomura I, Sata M, et al: Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002; 277: 37487-37491.
10. Chen ZP, Mitchelhill KI, Michell BJ, et al: AMP activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 1999; 443: 285-289.
11. Ouchi N, Kihara S, Arita Y, et al: Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 1999; 100: 2473-2476.
12. Hopkins TA, Ouchi N, Shibata R, Walsh K: Adiponectin actions in the cardiovascular system. Cardiovasc Res 2007; 74: 11-18.
13. Spranger J, Kroke A, Mohlig M, et al: Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361: 226-228.
14. Lindsay RS, Resnick HE, Zhu J, et al: Adiponectin and coronary heart disease: The Strong Heart Study. Arterioscler Thromb Vasc Biol 2005; 25: E15-e16.
15. Lawlor DA, Davey Smith G, Ebrahim S, Thompson C, Sattar N: Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 2005; 90: 5677-5683.
16. Sattar N, Wannamethee G, Sarwar N, Tchemova J, Cherry L, Wallace AM: Adiponectin and coronary heart disease: A prospective study and meta-analysis. Circulation 2006; 114: 623-629.
17. Kistorp C, Faber J, Galatius S, et al: Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005; 112: 1756-1762.
18. Nakamura T, Funayama H, Kubo N, et al: Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure. Circ J 2006; 70: 1557-1562.
19. Wannamethee SG, Whincup PH, Lennon L, Sattar N: Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med 2007; 167: 1510-1517.
20. Menon V, Li L, Wang X, et al: Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006; 17 2599-2606.